CA Patent

CA2804940C — Process for the synthesis of substituted morphinans

Assigned to Alkermes Pharma Ireland Ltd · Expires 2017-03-07 · 9y expired

What this patent protects

The present invention relates to a process for the synthesis of a compound of formula (I):

USPTO Abstract

The present invention relates to a process for the synthesis of a compound of formula (I):

Drugs covered by this patent

Zyprexa (olanzapine) · Eli Lilly

Patent Metadata

Patent number: CA2804940C
Jurisdiction: CA
Classification: —
Expires: 2017-03-07
Drug substance claim: No
Drug product claim: No
Assignee: Alkermes Pharma Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.